NDAINJECTIONINJECTABLE
Approved
Feb 1981
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
TECHNESCAN HDP (technetium tc 99m oxidronate) by Curium Pharma is clinical pharmacology during the 24 hours following injection, technetium tc 99m oxidronate is cleared from blood and other non-osseous tissues and accumulates in the skeleton and urine in humans. First approved in 1981.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TECHNESCAN HDP (Technetium Tc 99m Oxidronate) is a radiopharmaceutical diagnostic agent approved in 1981 for skeletal imaging. It accumulates in areas of altered bone metabolism and actively metabolizing bone, enabling visualization of osteogenesis and bone pathology. The agent is cleared from blood within hours and localizes to the skeleton, with approximately 50% retention at 24 hours post-injection.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%); commercial teams should anticipate downsizing and transition planning.
Mechanism of Action
CLINICAL PHARMACOLOGY During the 24 hours following injection, technetium Tc 99m oxidronate is cleared from blood and other non-osseous tissues and accumulates in the skeleton and urine in humans. Blood levels are about 10% of the injected dose at one hour post-injection and continue to fall to…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TECHNESCAN HDP offers limited growth opportunities given the approaching LOE and minimal linked job openings (zero recorded). Career value lies in managing mature asset optimization, defending market share, and transitioning to next-generation radiopharmaceuticals within Curium's portfolio.
Product Manager
Worked on TECHNESCAN HDP at Curium Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.